They've been see sawing.
revenue for Q4 when you compare to full year and prior year theyve hardly gone anywhere. They've cut costs and issued themselves more shares but otherwise in terms of top line growth revenue has been lack lustre. A meaningful increase from the china partnerships will be key...if or when it happens.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
RLG
roolife group ltd
Add to My Watchlist
0.00%
!
0.4¢

They've been see sawing.revenue for Q4 when you compare to full...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.371M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $120 | 30K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 2992247 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 4650000 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 2992247 | 0.004 |
9 | 3331092 | 0.003 |
4 | 4344980 | 0.002 |
2 | 2100000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 4650000 | 7 |
0.006 | 9179806 | 7 |
0.007 | 4336998 | 5 |
0.010 | 750000 | 1 |
0.018 | 500062 | 1 |
Last trade - 13.38pm 27/06/2025 (20 minute delay) ? |
Featured News
RLG (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online